Physician profile
David B Walker
NPI 1215111687
$1,637.24
in general payments reported to CMS, 2019-2025
21 companies · $569 in 2025
The $569 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.99 · 2020: $45.51 · 2021: $301 · 2022: $140 · 2023: $223 · 2024: $268 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,060.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $203.62 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.60 | 2019-2025 | Jardiance |
| Biosense Webster, INC. | $160.51 | 2025 | Carto 3 |
| Alnylam Pharmaceuticals INC. | $158.79 | 2025 | Amvuttra, Onpattro |
| Abbott Laboratories | $149.23 | 2021 | |
| Celgene Corporation | $132.91 | 2023-2024 | Camzyos |
| Medtronic, INC. | $122.30 | 2022-2025 | Corevalve Evolut R |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $121.71 | 2019-2025 | Lifevest |
| Irhythm Technologies, INC. | $61.27 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $47.81 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $44.93 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $43.60 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $41.29 | 2025 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $38.17 | 2023-2024 | Optimizer, Optimizer |
| Amgen INC. | $35.18 | 2020-2025 | Repatha |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $25.96 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $19.00 | 2023 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $17.14 | 2022 | |
| Boston Scientific Corporation | $17.07 | 2023 | Watchman Access System |
| Sanofi-Aventis U.S. LLC | $16.43 | 2019 | |
| Pfizer INC. | $13.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.